Published • loading... • Updated
Prediction of HER2 FISH result from registered H&E and IHC slides in breast cancer
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Prediction of HER2 FISH result from registered H&E and IHC slides in breast cancer
Background Human epidermal growth factor receptor 2 (HER2) is a key molecular biomarker in breast cancer, guiding targeted therapy. In current clinical practice, pathologists assess HER2 expression by examining immunohistochemistry (IHC) and hematoxylin and eosin (H&E) sli...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
